[Comparative analysis of associated live viral vaccines against measles and mumps].
Vaccinations and revaccinations by a new Russian live associated mumps-measles vaccine and by a live trivaccine (measies-mumps-rubella)--"Priorix--were performed. We followed up 139 infants vaccinated at an age of 12-18 months, 122 children vaccinated at an age of 6-7 years and 129 persons vaccinated at an age of 18-10 years. The combined vaccines were found to be low reactogenic and high immunogenic preparations.